Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jovan, Todorovic"'
Autor:
Knoll, Lisa, Hamm, Jacob, Stroebel, Philipp, Jovan, Todorovic, Goetze, Robert, Singh, Shiv, Hessmann, Elisabeth, Ellenrieder, Volker, Ammer-Herrmenau, Christoph, Neesse, Albrecht
Publikováno v:
In Neoplasia July 2024 53
Autor:
Alexander Rühle, Jovan Todorovic, Simon S. K. Spohn, Eleni Gkika, Christoph Becker, Andreas Knopf, Constantinos Zamboglou, Tanja Sprave, Martin Werner, Anca-Ligia Grosu, Gian Kayser, Nils H. Nicolay
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-12 (2022)
Abstract Background and purpose Tumor-infiltrating lymphocytes (TILs) are associated with locoregional control (LRC) in head-and-neck squamous cell carcinoma (HNSCC) patients undergoing (chemo)radiotherapy. As immunosenescence results in reduced immu
Externí odkaz:
https://doaj.org/article/1e1becab28f1449e921cca6d2bc72d54
Autor:
Beate Jahn, Gaby Sroczynski, Marvin Bundo, Nikolai Mühlberger, Sibylle Puntscher, Jovan Todorovic, Ursula Rochau, Willi Oberaigner, Hendrik Koffijberg, Timo Fischer, Irmgard Schiller-Fruehwirth, Dietmar Öfner, Friedrich Renner, Michael Jonas, Monika Hackl, Monika Ferlitsch, Uwe Siebert, on behalf of the Austrian Colorectal Cancer Screening Model Group
Publikováno v:
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-13 (2019)
Abstract Background Clear evidence on the benefit-harm balance and cost effectiveness of population-based screening for colorectal cancer (CRC) is missing. We aim to systematically evaluate the long-term effectiveness, harms and cost effectiveness of
Externí odkaz:
https://doaj.org/article/7ba03dc1808447f28e6103f1b6a16632
Autor:
Beate Jahn, Júlia Santamaria, Hans Dieplinger, Christoph J. Binder, Christoph Ebenbichler, Sabine Scholl-Bürgi, Annette Conrads-Frank, Ursula Rochau, Felicitas Kühne, Igor Stojkov, Jovan Todorovic, Lyndon James, Uwe Siebert
Publikováno v:
Atherosclerosis. 355
FH is still underdiagnosed. Cost-effectiveness results of preventive screening strategies vary. We aimed at systematically assessing the benefits, harms and cost effectiveness of screening for familial hypercholesterolemia (FH) and at providing an ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a11e01900453794f93261cec27fd1428
https://pubmed.ncbi.nlm.nih.gov/35870306
https://pubmed.ncbi.nlm.nih.gov/35870306
Autor:
Beate Jahn, Gaby Sroczyn, Marvin Bundo, Nikolai Mühlberger, Sibylle Puntscher, Jovan Todorovic, Ursula Rochau, Wilhelm Oberaigner, Hendrik Koffijberg, Timo Fischer, Irmgard Schiller-Frühwirth, Dietmar Öfner, Friedrich Renner, Michael Jonas, Monika Hackl, Monika Ferlitsch, Uwe Siebert
Background: Clear evidence on the benefit-harm balance and cost effectiveness of population-based screening for colorectal cancer (CRC) is missing. We aim to systematically evaluate the long-term effectiveness, harms and cost effectiveness of differe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d683ccd4ac466d83023cd54e90ef8e6
https://doi.org/10.21203/rs.2.11419/v1
https://doi.org/10.21203/rs.2.11419/v1
Autor:
Jovan Todorovic, Beate Jahn, Niki Popper, Annette Conrads-Frank, Gottfried Endel, Marvin Bundo, Dan Greenberg, Ingrid Wilbacher, Jagpreet Chhatwal, Ursula Rochau, Nikoletta Malbaski, Gaby Sroczynski, Uwe Siebert, Josephine Mauskopf
Publikováno v:
Applied health economics and health policy. 17(4)
Budget impact analyses (BIAs) describe changes in intervention- and disease-related costs of new technologies. Evidence on the quality of BIAs for cancer screening is lacking. We systematically reviewed the literature and methods to assess how closel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e35009eb58d5e8ba335bccd51ed2f2f
https://pubmed.ncbi.nlm.nih.gov/31016686
https://pubmed.ncbi.nlm.nih.gov/31016686
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.